Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease
Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…Vestibular impairment, turning direction and turn progression in Parkinson’s disease
Objective: To explore the correlation between the Romberg test condition 4 and turn progression in most affected and least affected body side directions in people…Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients
Objective: To investigate the role of family, environmental and professional factors in Parkinson's disease (PD) development. Background: Parkinson's disease (PD) is a neurological disorder with…Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.
Objective: Identify the predisposing or exacerbating factors of sleep disorders in Parkinson's disease, and examine their association with levodopa treatment. Background: Parkinson's disease (PD) is…Atypical Parkinsonism Secondary to Recurrent Deep Vein Thrombosis with Associated Intracranial Dural Fistula
Objective: This report aims to present a case of atypical parkinsonism that is secondary to recurrent deep vein thrombosis with associated intracranial dural fistula. Background:…Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease
Objective: The objective of our study was to assess prospectively the neuropsychiatric features in sCJD (and their impact on caregivers) and compare them with five…Cognitive Performance in Early Neuronal alpha-Synuclein Disease
Objective: To determine if cognitive deficits can be detected in early-stage Neuronal alpha-Synuclein Disease (NSD) compared with healthy controls. Background: Global cognitive deficits have been…Misdiagnosis of Cognitive Impairment in Parkinson’s disease
Objective: We explored potential bias to diagnose cognitive impairment in People with Parkinson’s (PwP) followed in the Parkinson’s Progressive Markers Initiative (PPMI). Background: In primary…Cognitive Reserve and Motor Subtypes of Parkinson’s Disease
Objective: To assess differences in cognitive reserve (CR) between motor subtypes of patients with Parkinson’s disease (PD). Background: Motor subtypes in patients with PD have…Personality of Parkinson’s disease patients may influence the development and evolution of non-motor fluctuations
Objective: to evaluate the impact of personality on non-motor fluctuations (NMFs) in Parkinson’s disease (PD) and on NMFs evolution after dopaminergic treatments or deep brain…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 181
- Next Page »